Search clinical trials for: Incretin response

Total 14992 results

University Hospital, Gentofte, Copenhagen
The Novo Nordisk Foundation Center for Basic Metabolic Research

Recruiting

The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients With Type 1 Diabetes (GIPHYPO)

Hypoglycemia | Type1diabetes | Type 1 Diabetes

Denmark
The Affiliated Hospital of Xuzhou Medical University

Recruiting

Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM

Type 2 Diabetes Mellitus

China
University of Pennsylvania
Children's Hospital of Philadelphia

Recruiting

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

Cystic Fibrosis | Pancreatic Insufficiency

United States
The University of Texas Health Science Center at...

Recruiting

Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

Hypoglycemia | Post Bariatricsurgery

United States
Vanderbilt University Medical Center

Active, not recruiting

Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1

Hypertension

United States
University of Palermo

Completed

Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients

Diabetes Mellitus, Type 2

Italy
Texas Tech University
Novo Nordisk A/S

Completed

To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity

Obesity

United States
University Hospital Muenster

Completed

Perioperative Sitagliptin Medication for Reduction of the Inflammatory Response Associated With Cardiopulmonary Bypass (SiCa-Flam)

Systemic Inflammatory Response Syndrome

Germany
The University of Texas Health Science Center at...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria

Diabetes Mellitus, Type 2

United States
Société des Produits Nestlé (SPN)
Peking Union Medical College Hospital

Completed

Efficacy of Milk Product Supplemented With Bioactives in Lowering Post Meal Glucose Response

Healthy | PreDiabetes | Adult | Asian

China
Yale University

Completed

Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.

Obesity, Childhood | Neural Development

United States
University Hospital, Gentofte, Copenhagen

Completed

The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes (GA-16)

Type2 Diabetes

Denmark
University of Nottingham

Completed

Effect of Oral Feeding on Gastric Emptying, Gut Blood Flow, and Hormone Responses in Obese and Healthy Weight Subjects

Obesity

United Kingdom
National University of Malaysia

Completed

Linagliptin Response to OGTT in Prediabetes and Type 2 Diabetes Mellitus

PreDiabetes | Type 2 Diabetes

Malaysia
The University of Hong Kong

Completed

Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy

Type 2 Diabetes | Ketonemia

Hong Kong
Xeris Pharmaceuticals
Integrated Medical Development

Terminated

Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses

Diabetes Mellitus, Type 1 | Hypoglycemia Unawareness

United States
Novo Nordisk A/S

Completed

Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes (PIONEER 9)

Diabetes Mellitus, Type 2 | Diabetes

Japan
University of Padova

Completed

Effect of Ingestion of Human, Cow, and Modified-cow Milk, on Glucose and Hormone Responses in Humans. (PROLAT)

Hormone | Insulin Tolerance | Aminoacidaemia
University College, London

Completed

Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response (BARIOPTIMISE)

Obesity

United Kingdom
Beni-Suef University

Completed

Tubular Markers in Response to Saxagliptin Therapy

Diabetes Mellitus, Type 2

Egypt
University of Copenhagen

Completed

GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations

Obesity

Denmark
University of Pittsburgh
National Institutes of Health (NIH); National Institute of General Medical...

Completed

Study of Early Enteral Dextrose in Sepsis (SEEDS)

Sepsis

United States
University of Aarhus
University of Copenhagen

Completed

Acute Metabolic Effects of Melatonin Treatment

Glucose Metabolism Disorders

Denmark
Peking Union Medical College Hospital
Chinese Academy of Sciences

Unknown

Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents

Type2 Diabetes Mellitus

China
Imperial College London Diabetes Centre

Unknown

Effect of Camel Milk on Insulin and Incretin Response

Glucose Tolerance | Insulin Sensitivity

United Arab Emirates
Merck Sharp & Dohme LLC

Completed

Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105)

Glucose Intolerance
University of Missouri-Columbia
American Egg Board

Completed

Impact of Breakfast Composition on Glycemic and Incretin Responses in Individuals With Type 2 Diabetes

Type 2 Diabetes
Lund University
Kalmar County Hospital

Withdrawn

Changes in Incretins Response and Glycemic Control After Gastric Bypass Surgery in Type 2 Diabetic Patients Versus Healthy

Obesity | Type 2 Diabetes

Sweden
Xeris Pharmaceuticals
The Emmes Company, LLC

Completed

Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients

Diabetes Mellitus, Type 1

United States
Royal Devon and Exeter NHS Foundation Trust
University of Exeter

Completed

MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 Diabetes (Mastermind)

Type 2 Diabetes

United Kingdom
Royal Devon and Exeter NHS Foundation Trust
National Institute for Health Research, United Kingdom; University of Exeter

Completed

Predicting Response to Incretin Based Agents in Type 2 Diabetes (PRIBA)

Type2 Diabetes

United Kingdom
University Medical Centre Ljubljana

Completed

GLP-1 Response in Women With PCOS and Prediabetes

Incretin Hormones in PCOS With Prediabetes

Slovenia
University of Dundee

Completed

Response To Oral Agents in Diabetes (ROAD)- Pilot Study (ROAD)

Diabetes Mellitus, Type 2

United Kingdom
Seattle Children's Hospital

Withdrawn

Pharmacology of Exenatide in Pediatric Sepsis (PEPS)

Inflammation | Septic Shock | Glucose Homeostasis | Organ Dysfunction | Health-related Quality of Life

United States
Novo Nordisk A/S

Completed

The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Stanford University

Completed

Exenatide and Weight Loss for Diabetes Prevention

Insulin Resistance | Pre Diabetes
Charles University, Czech Republic

Completed

Incretin Effects of Branched Chain Amino Acids

Glucose Metabolism Disorders

Czech Republic
Indiana University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Modulation of Human Myocardial Metabolism by GLP-1 Dose Response

Healthy | Type 2 Diabetes Mellitus

United States
PhaseBio Pharmaceuticals Inc.

Completed

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

Type 2 Diabetes Mellitus

United States
University Medical Centre Ljubljana

Completed

Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome

Obesity | PCOS

Slovenia
Eli Lilly and Company

Completed

Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose

Diabetes Mellitus, Type 2

Germany
Postgraduate Institute of Medical Education and...

Unknown

Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus | Insulin Sensitivity/Resistance

India
Novartis Pharmaceuticals

Withdrawn

Dose-finding Study of LIK066 Compared With Placebo or Sitagliptin to Evaluate Change in HbA1c in Patients With Diabetes

Type 2 Diabetes Mellitus
Lund University

Completed

Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion

Healthy | Type 2 Diabetes

Sweden
Lund University

Completed

Metabolic Effects of a Pre-meal Protein Drink With or Without Added Amino Acids at a Subsequent Composite Meal

Diabetes Mellitus, Type 2 | Satiety Response

Sweden
University Hospital, Gentofte, Copenhagen
The Novo Nordic Foundation; Aase and Ejnar Danielsens Foundation; The Danish...

Completed

Study of Postprandial Incretin Response in Women With Gestational Diabetes

Gestational Diabetes Mellitus

Denmark
Aarhus University Hospital
Arla Foods; The Danish Obesity Research Centre; Nordic Centre of Excellence

Completed

Effects of Dietary Proteins on Postprandial Lipaemia and Incretin Responses in Obese Subjects

Postprandial Inflammation | Postprandial Lipaemia | Postprandial Incretins

Denmark
Aarhus University Hospital
The Danish Obesity Research Centre; Nordic Centre of Excellence

Completed

Acute Effects of Dietary Proteins on Postprandial Lipemia, Incretin Responses and Subclinical Inflammation in Obese Subjects

Inflammation | Obesity | Atherosclerosis | Postprandial Lipemia | Postprandial Incretins

Denmark
Hvidovre University Hospital

Completed

Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus

Type 1 Diabetes

Denmark
Aarhus University Hospital
The Danish Obesity Research Centre; Nordic Centre of Excellence

Completed

Differential Effects of Protein Quality on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes: Comparison of Whey, Casein, Gluten, and Cod Protein

Type 2 Diabetes | Postprandial Lipemia

Denmark

Search clinical trials for: Incretin response

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations